SOLOPHARM the company started the production of viscoelastics, solutions, necessary for carrying out surgical interventions on the eyeball. The company noted that SOLOPHARM became the first Russian company that developed technology for the production of viscoelastics based on hyaluronic acid and chondroitin.
The viscoelastics serve to maintain the volume of the anterior chamber of the eye during surgery, performing protective and compensatory functions. To their quality and properties of viscosity, elasticity and transparency high demands. Often the viscoelastics used in the surgical treatment of cataracts.